Regeneration of articular cartilage using adipose stem cells
Source abstract
Abstract
Abstract Articular cartilage (AC) has limited potential for self‐regeneration and damage to AC eventually leads to the development and progression of osteoarthritis (OA). Cell implantation strategies have emerged as a new treatment modality to regenerate AC. Adipose stem cells/adipose‐derived stromal cells (ASCs) have gained attention due to their abundance, excellent proliferative potential, and minimal morbidity during harvest. These advantages lower the cost of cell therapy by circumventing time‐consuming procedure of culture expansion. ASCs have drawn attention as a potential source for cartilage regeneration since the feasibility of chondrogenesis from ASCs was first reported. After several groups reported inferior chondrogenesis from ASCs, numerous methods were devised to overcome the intrinsic properties. Mostin vivoanimal studies have reported good results using predifferentiated or undifferentiated, autologous or allogeneic ASCs to regenerate cartilage in osteochondral defects or surgically‐induced OA. In this review, we summarize literature on the isolation andin vitrodifferentiation processes of ASCs,in vivostudies to regenerate AC in osteochondral defects and OA using ASCs, and clinical applications of ASCs. © 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 104A: 1830–1844, 2016.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Osteoarthritis Treatment and Mechanisms · Mesenchymal stem cell research · Periodontal Regeneration and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Orthopedics Dongguk University Ilsan Hospital Goyang Korea
References (100+)
Show source-provided references
1. 10.2174/15748880978964920510.2174/157488809789649205 ↗
2. 10.1007/s12178-012-9135-x10.1007/s12178-012-9135-x ↗
3. Cartilage repair and joint preservation: Medical and surgical treatment options
4. 10.1056/NEJM19941006331140110.1056/NEJM199410063311401 ↗
5. 10.1016/j.injury.2010.09.02810.1016/j.injury.2010.09.028 ↗
6. 10.1002/jcb.2088610.1002/jcb.20886 ↗
7. 10.1186/1756-9966-30-910.1186/1756-9966-30-9 ↗
8. 10.1007/s12015-011-9312-010.1007/s12015-011-9312-0 ↗
9. 10.1089/ten.2005.11.119810.1089/ten.2005.11.1198 ↗
10. 10.1186/ar251410.1186/ar2514 ↗
11. 10.1091/mbc.e02-02-010510.1091/mbc.e02-02-0105 ↗
12. 10.1089/scd.2011.072210.1089/scd.2011.0722 ↗
13. 10.1016/j.joca.2005.05.00510.1016/j.joca.2005.05.005 ↗
14. 10.1111/j.1524-4725.1990.tb00017.x10.1111/j.1524-4725.1990.tb00017.x ↗
15. 10.1097/00006534-198607000-0002810.1097/00006534-198607000-00028 ↗
16. 10.1016/S0094-1298(20)31069-510.1016/S0094-1298(20)31069-5 ↗
17. 10.1007/BF0045387510.1007/BF00453875 ↗
18. 10.1155/2014/74092610.1155/2014/740926 ↗
19. 10.1016/j.bjps.2012.06.01410.1016/j.bjps.2012.06.014 ↗
20. 10.1016/j.bjps.2013.04.01510.1016/j.bjps.2013.04.015 ↗
21. 10.1016/j.ymeth.2008.03.00610.1016/j.ymeth.2008.03.006 ↗
22. 10.1089/10763270130006285910.1089/107632701300062859 ↗
23. 10.1007/s11010-005-5996-210.1007/s11010-005-5996-2 ↗
24. 10.1089/ten.tea.2008.036810.1089/ten.tea.2008.0368 ↗
25. 10.1111/j.1365-2184.2007.00473.x10.1111/j.1365-2184.2007.00473.x ↗
26. 10.1002/art.2121210.1002/art.21212 ↗
27. 10.1002/art.2165110.1002/art.21651 ↗
28. 10.1093/rheumatology/kem21710.1093/rheumatology/kem217 ↗
29. 10.1006/excr.1997.385810.1006/excr.1997.3858 ↗
30. 10.1089/ten.1998.4.41510.1089/ten.1998.4.415 ↗
31. 10.1186/scrt3110.1186/scrt31 ↗
32. 10.1006/excr.2001.527810.1006/excr.2001.5278 ↗
33. 10.1002/art.2177910.1002/art.21779 ↗
34. 10.1002/jcp.2097710.1002/jcp.20977 ↗
35. 10.1111/j.1439-0264.2006.00680.x10.1111/j.1439-0264.2006.00680.x ↗
36. 10.1089/scd.2010.035510.1089/scd.2010.0355 ↗
37. 10.1111/j.1365-2184.2010.00680.x10.1111/j.1365-2184.2010.00680.x ↗
38. 10.1002/jor.2076610.1002/jor.20766 ↗
39. 10.1089/10763270432279179010.1089/107632704322791790 ↗
40. 10.1002/term.5610.1002/term.56 ↗
41. 10.1272/jnms.71.24010.1272/jnms.71.240 ↗
42. 10.1016/j.msec.2003.12.01410.1016/j.msec.2003.12.014 ↗
43. 10.1016/j.bone.2008.07.24010.1016/j.bone.2008.07.240 ↗
44. 10.1039/c0sm00266f10.1039/c0sm00266f ↗
45. 10.1089/ten.tea.2010.021810.1089/ten.tea.2010.0218 ↗
46. 10.1089/ten.tea.2009.000210.1089/ten.tea.2009.0002 ↗
47. 10.1089/ten.2006.12.168710.1089/ten.2006.12.1687 ↗
48. 10.1080/0300820059095410410.1080/03008200590954104 ↗
49. 10.1016/j.bbrc.2007.06.00210.1016/j.bbrc.2007.06.002 ↗
50. 10.1111/j.1582-4934.2008.00278.x10.1111/j.1582-4934.2008.00278.x ↗
51. 10.1002/jcp.108110.1002/jcp.1081 ↗
52. 10.1053/joca.2001.047710.1053/joca.2001.0477 ↗
53. 10.1007/s00441-013-1732-510.1007/s00441-013-1732-5 ↗
54. 10.1016/j.bbrc.2014.04.09610.1016/j.bbrc.2014.04.096 ↗
55. 10.1126/science.184.4136.57510.1126/science.184.4136.575 ↗
56. 10.1152/japplphysiol.01216.201210.1152/japplphysiol.01216.2012 ↗
57. 10.2741/s13310.2741/s133 ↗
58. 10.1016/j.drudis.2011.07.00910.1016/j.drudis.2011.07.009 ↗
59. 10.1016/j.biomaterials.2007.03.00210.1016/j.biomaterials.2007.03.002 ↗
60. 10.1002/jbm.a.3165610.1002/jbm.a.31656 ↗
61. Repair of articular cartilage defects by autologous adipose derived mesenchymal stem cell: Experiment with rabbits
62. 10.1089/ten.tea.2012.001010.1089/ten.tea.2012.0010 ↗
63. The effects of BMP6 overexpression on adipose stem cell chondrogenesis: Interactions with dexamethasone and exogenous growth factors10.1002/jbm.a.32589 ↗
64. 10.1186/ar426010.1186/ar4260 ↗
65. 10.1002/jcp.2292710.1002/jcp.22927 ↗
66. 10.1016/S0945-053X(00)00094-910.1016/S0945-053X(00)00094-9 ↗
67. 10.1128/MCB.17.4.233610.1128/MCB.17.4.2336 ↗
68. 10.1002/(SICI)1097-0177(199708)209:4<377::AID-AJA5>3.0.CO;2-F10.1002/(SICI)1097-0177(199708)209:4<377::AID-AJA5>3.0.CO;2-F ↗
69. 10.1002/jor.2133610.1002/jor.21336 ↗
70. 10.1128/MCB.00695-0810.1128/MCB.00695-08 ↗
71. 10.1016/j.ydbio.2010.02.02410.1016/j.ydbio.2010.02.024 ↗
72. 10.1016/j.biomaterials.2011.06.05910.1016/j.biomaterials.2011.06.059 ↗
73. 10.1016/j.biomaterials.2011.11.05010.1016/j.biomaterials.2011.11.050 ↗
74. 10.1016/j.biomaterials.2011.02.05410.1016/j.biomaterials.2011.02.054 ↗
75. 10.1016/j.arthro.2013.09.07610.1016/j.arthro.2013.09.076 ↗
76. Cartilage‐like gene expression in differentiated human stem cell spheroids: A comparison of bone marrow‐derived and adipose tissue‐derived stromal cells. Arthritis
77. 10.1007/s00441-008-0633-510.1007/s00441-008-0633-5 ↗
78. 10.1002/jor.2093310.1002/jor.20933 ↗
79. 10.1016/j.biomaterials.2012.06.05810.1016/j.biomaterials.2012.06.058 ↗
80. 10.3109/1073119100377676910.3109/10731191003776769 ↗
81. 10.1002/jor.2111410.1002/jor.21114 ↗
82. 10.1089/ten.2006.024910.1089/ten.2006.0249 ↗
83. 10.1016/j.biomaterials.2009.01.04510.1016/j.biomaterials.2009.01.045 ↗
84. 10.3727/09636890978834126110.3727/096368909788341261 ↗
85. 10.1016/j.jbspin.2009.05.01310.1016/j.jbspin.2009.05.013 ↗
86. 10.1002/jbm.b.3050710.1002/jbm.b.30507 ↗
87. Proteomic analysis profile of engineered articular cartilage with chondrogenic differentiated adipose tissue‐derived stem cells loaded polyglycolic acid mesh for weight‐bearing area defect repair
88. 10.1089/10763270376824741210.1089/107632703768247412 ↗
89. Uninduced adipose‐derived stem cells repair the defect of full‐thickness hyaline cartilage
90. 10.4238/2014.June.18.210.4238/2014.June.18.2 ↗
91. 10.1186/scrt27710.1186/scrt277 ↗
92. Repair of osteochondral defects with adipose stem cells and a dual growth factor‐releasing scaffold in rabbits10.1002/jbm.b.31552 ↗
93. 10.1186/s13018-015-0173-010.1186/s13018-015-0173-0 ↗
94. 10.1016/j.joca.2011.11.01010.1016/j.joca.2011.11.010 ↗
95. 10.1002/art.1011810.1002/art.10118 ↗
96. 10.1016/j.jcyt.2013.08.01310.1016/j.jcyt.2013.08.013 ↗
97. 10.2174/15748881079044279610.2174/157488810790442796 ↗
98. 10.1016/j.knee.2010.03.00110.1016/j.knee.2010.03.001 ↗
99. Scaffold‐free adipose‐derived stem cells (ASCs) improve experimentally induced osteoarthritis in rabbits
100. 10.1186/ar415610.1186/ar4156 ↗